Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells

Chemistry and Biology

Volumn 3, Issue 11, 1996, Pages 905-912

  Fenteany, Gabriel ^a   Schreiber, Stuart L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

chymotrypsin like activity; lactacystin; neurite outgrowth; peptide aldehydes; proteasome

Indexed keywords

EID: 0030294381     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(96)90179-9     Document Type: Article

References (43)

1. Ōmura, S., et al., & Sasaki, Y. (1991). Lactacystin, a novel microbial metabolite, induces neuritogenests of neuroblastoma cells. J. Antibiotics 44, 113-116.
2. Fenteany, G., Standaert, R.F., Reichard, G.A., Corey, E.J. & Schreiber, S.L. (1994). A β-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc. Natl. Acad. Sci. USA 91, 3358-3362.
3. Tsuji, S., Yamashita, T., Tanaka, M. & Nagai, Y. (1988). Synthetic sialyl compounds as well as natural gangliosides induce neuritogenesis in a mouse neurobtastoma cell line (Neuro2A). J. Neurochem. 50, 414-423.
4. Mitsui, K., Tsuji, S., Yamazaki, M. & Nagai, Y. (1991). Multiple neurite formation in neuroblastoma cell lines by griseolic acid, a potent inhibitor of cyclic nucleotide phosphodiesterases. Neurochem. 57, 556-561.
5. Tanaka, H., Katagiri, M., Arima, S., Matsuzaki, K., Inokoshi, J. & Ōmura, S. (1995). Neuronal differentiation of Neuro 2A cells by lactacystin and its partial inhibition by the protein phosphatase inhibitors calycutin A and okadaic acid. Biochem. Biophys. Res. Commun. 216, 291-297.
6. 2 phases in Neuro 2A cells. J. Antibiotics 48, 344-346.
7. Fenteany, G., Standaert, R.F., Lane, W.S., Choi, S., Corey, E.J. & Schreiber, S.L. (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268, 726-731.
8. Peters, J.-M. (1994). Proteasomes: protein degradation machines of the cell. Trends Biochem. Sci. 19, 377-382.
9. Goldberg, A.L., Stein, R. & Adams, J. (1995). New insights into proteasome function: from archaebacteria to drug development. Chemistry & Biology 2, 503-508.
10. Hilt, W. & Wolf, D.H. (1996). Proteasomes: destruction as a programme. Trends Biochem. Sci. 21, 96-102.
11. Coux, O., Tanaka, K. & Goldberg, A.L. (1996). Structure and function of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801-847.
12. Palombella, V.J., Rando, O.J., Goldberg, A.L. & Maniatis, T. (1994). The ubiquitin-proteasome pathway is required for processing of NF-κB1 precursor protein and the activation of NF-καB. Cell 78 773-785.
13. Orlowski, M., Cardoza, C. & Michaud, C. (1993). Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32, 1563-1572.
14. Jensen, T.J., Loo, M.A., Pind, S., Williams, D.B., Goldberg, A.L. & Riordan, J.R. (1995). Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129-135.
15. Craiu, A., et al., & Rock, K.L. (1996). The inhibitors lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and block protein degradation and MHC class I antigen presentation. J. Biol. Chem., in press.
16. Dick, L.R., Cruikshank, A.A., Grenier, L., Melandri, F.D., Nunes, S.L. & Stein, R.L. (1996). Mechanistic studies on the inactivation of the proteasome by lactacystin - a central role for clasto-lactacystin p-lactone. J. Biol. Chem. 271, 7273-7276.
17. Löwe, J., Stock, D., Jap, B., Zwickl, O., Baumeister, W. & Huber, R. (1995). Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science 268, 533-539.
18. Seemüller, E., Lupas, A., Stock, D., Löwe, J., Huber, R. & Baumeister, W. (1995). Proteasome from Thermoplasma acidophilum: a threonine protease. Science 268, 579-582.
19. Heinemeyer, W., Gruhler, A., Möhrle, V., Mahé, Y. & Wolf, D.H. (1993). PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chymotryptic activity and degradation of ubiquitinated proteins. J. Biol Chem. 268, 5115-5120.
20. Brannigan, J.A., et al., & Murzin, A.G. (1995). A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature 378, 416-419.
21. Oinonen, C., Tikkanen, R., Rouvinen, J. & Peltonen, L. (1895). Three-dimensional structure of human lysosomal aspartylglucosaminidase. Nat. Struct. Biol. 2, 1102-1108.
22. Tikkanen, R., Riikonen, A., Oinonen, C., Rouvinen, J. & Peltonen, L. (1996). Functional analyses of active site residues of human lysosomal aspartylglucosaminidase - implications for catalytic mechanism and autacatalytic activation. EMBO J. 15, 2954-2960.
23. Mason, G.G.F. & Rivett, A.J. (1994). Proteasomes: the changing face of proteolysis. Chemistry & Biology 1 197-199.
24. Fehling, H.J., et al., & von Boehmer, H. (1994). MHC class I expression in mice lacking proteasome subunit LMP7. Science 265, 1234-1237.
25. + proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Curr. Biol. 5, 923-930.
26. Driacoll, J., Brown, M.G., Finley, D. & Monaco, J.J. (1993). MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365, 262-264.
27. Gaczynska, M., Rock, K.L. & Goldberg, A.L. (1993). γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365, 264-267.
28. Aki, M., et al., & Ichihara, A. (1994). Interferon-γ induces different subunit organization and functional diversity or proteasomes. J. Biochem 115, 257-269.
29. Boes, B., Hengel, H., Ruppert, T., Malthaup, G., Koszinowski, D.H. & Kloetzel, P.M. (1994). Interferon-γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179, 901-909.
30. Akiyama, K., et al., & Noda, C. (1994). cDNA cloning and interferon-γ down-regulation of proteasomal subunits X and Y. Science 265, 1231-1234.
31. Belich, M.P., Glynne, R.J., Sengere, G., Sheer, D. & Trowsdale, J. (1994). Proteasome components with reciprocal expression to that of the MHC-encoded UMP proteins. Curr. Biol. 4, 769-776.
32. Früh, K., Gossen, M., Wang, K., Bujard, H., Peterson, P. & Yang, Y. (1994). Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 13, 3236-3244.
33. Hisamatsu, H., et al., & Tanaka, K. (1996). Newly identified pair of proteasomal subunits regulated reciprocally by interferon-γ. J. Exp. Med. 183, 1807-1816.
34. Groettrup, M., Kraft, R., Kostka, S., Standera, S., Stohwasser, R. & M., K.P. (1996). A third interferon-γ-induced subunit exchange in the 20S proteasome. Eur. J. Immun. 26, 863-869.
35. Vinitzky, A., Michaud, C., Powers, J.C. & Orlowski, M. (1992). Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 31, 9421-9428.
36. Rock, K.L., et al., & Goldberg, A.L. (1994). Inhibitors of the proteasome block degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771.
37. Wilk, S. & Orlowski, M. (1983). Evidence that pituitary cation-sensitive neutral endopeptidase is a multicatalytic protease complex. J. Neurochem. 40, 842-849.
38. Cardoza, C., Vinitsky, A., Hidalgo, M.C., Michaud, C. & Orlowski, M. (1992). A 3,4-dichloroisocoumarin-resistant component of the multicatalytic proteinase complex. Biochemistry 31, 7373-7380.
39. Atsma, D.E., Bastiaanse, E.M., Jerzewski, A., van der Valk, L.J. & van der Laarse, A. (1995). Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. Circ. Res. 76, 1071-1078.
40. Grinde, B. & Seglen, P.O. (1980). Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes. Biochim. Biophys. Acta 632, 73-86.
41. Umezawa, H. (1976). Structures and activities of protease inhibitors of microbial origin. In Methods in Enzymology. (Lorand, L., ed.), pp. 678-695, Academic Press, NY, USA.
42. Seglen, P.O. (1983). Inhibitors of lysosomal function. In Methods in Enzymology. (Fleischer, S. & Fleischer, B., eds), pp. 737-764, Academic Press, NY, USA.
43. Taubuki, S., Kawasaki, H., Saito, Y., Miyashita, N., Inomata, M. & Kawashima, S. (1994). Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: a novel catalytic activity in proteasome. Biochem. Biophys. Res. Commun. 196, 1195-1201.